Symptomatic venous thromboembolism and thrombophilic status in adult acute leukemia: A single-center experience of 114 patients at diagnosis

Acta Haematologica

Volumn 117, Issue 4, 2007, Pages 215-220

  Melillo, Lorella ^a,b   Grandone, Elvira ^a   Colaizzo, Donatella ^a   Cappucci, Filomena ^a   Valvano, Maria Rosa ^a   Cascavilla, Nicola ^a  

^a IRCCS   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Adult acute leukemia; Thromboembolic events; Thrombophilia

Indexed keywords

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ADULTHOOD; AGED; ARTICLE; CLINICAL EVALUATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERHOMOCYSTEINEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; RISK FACTORS; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 34249030620     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098700     Document Type: Article

References (23)

1. Leone G, Sica S, Chiusolo P, Teofili L, De Stefano V: Blood cell diseases and thrombosis. Haematologica 2001;86:1236-1244.
2. Cortellezzi A, Moia M, Falanga A, Pogliani EM, Agnelli G, Bonizzoni E, Gussoni G, Barbui T, Mannucci PM, on behalf of the CATHEM Study Group: Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study. Br J Haematol 2005;129:811-817.
3. Nowak-Gottl U, Wermes C, Junker R, Koch HG, Schobess R, Fleischhack G, Schwabe D, Ehrenforth S: Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT677 genotype, the prothrombin G20210A variant and further prothrombotic risk factors. Blood 1999;93:1595-1599.
4. De Stefano V, Sorà F, Rossi E, Chiusolo P, Laurenti L, Fianchi L, Zini G, Pagano L, Sica S, Leone G: The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost 2005;3:1985-1992.
5. Ziegler S, Wolfgang RS, Knobl P, Lehr S, Weltermann A, Jager U, Valent P, Lechner K: Symptomatic venous thromboembolism in acute leukemia: incidence, risk factors and impact on prognosis. Thromb Res 2005;115:59-64.
6. Lo Coco F, Nervi C, Avvisati G, Mandelli F: Acute promyelocytic leukemia: a curable disease. Leukemia 1998;12:1866-1880.
7. Exner T, Triplett DA, Taberner D, Machin SJ: Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants. Thromb Haemost 1991;65:320-322.
8. Magera MJ, Lacey JM, Casetta B, Rinaldo P: Method for the determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry. Clin Chem 1999;45:1517-1522.
9. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G, Sciannamè N, Pavone G, Di Minno G: Factor V Leiden is associated with repeated and recurrent fetal losses. Thromb Haemost 1997;77:822-824.
10. Margaglione M, Brancaccio V, Giuliani N, D'Andrea G, Cappucci G, Iannaccone L, Vecchione G, Grandone E, Di Minno G: Increased risk for venous thrombosis in carriers of the prothrombin G→A 20210 gene variant. Ann Intern Med 1998;129:89-93.
11. Grandone E, Margaglione M, Colaizzo D, D'Andrea G, Cappucci G, Brancaccio V, Di Minno G: Genetic susceptibility to pregnancy-related venous thromboembolism: role of factor V Leiden, prothrombin G20210A and C677T methylenetetrahydrofolate reductase mutations. Am J Obstet Gynecol 1998;179:1324-1328.
12. Carlsson H, Stockelberg D, Tengborn L, Braide I, Carneskog J, Kutti J: Effects of Erwinia-asparaginase on the coagulation system. Eur J Haematol 1995;55:289.
13. Falanga A, Barbui T: Coagulopathy of acute promyelocytic leukemia. Acta Haematol 2001;106:43-51.
14. Rodeghiero F, Mannucci PM, Vigano S, Barbui T, Gugliotta L, Cortellaro M, Dini E: Liver dysfunction rather than intravascular coagulation as the main cause of low protein C and antithrombin III in acute leukemia. Blood 1984;63:965-969.
15. Lossos IS, Bogomolski-Yahalom V, Matzner Y: Anticardiolipin antibodies in acute myeloid leukemia: prevalence and clinical significance. Am J Hematol 1998;57:139-143.
16. Galli M, Luciani D, Bertolini G, Barbui T: Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003;101:1827-1832.
17. De Stefano V, Casorelli I, Rossi E, Zappacosta B, Leone G: Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism. Semin Thromb Hemost 2000;26:305-311.
18. Tallman M, Brenner B, De la Serna J, Dombret H, Falanga A, Kwaan HC, Liebmann H, Raffoux E, Rickles FR: Meeting report. Leukemia Res 2005;29:347-351.
19. Gugliotta L, Mazzucconi MG, Leone G, Mattioli-Belmonte M, Defazio P, Annino L, Tura S, Mandelli F: Incidence of thrombotic complications in adult patients with lymphoblastic leukemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group. Eur J Haematol 1992;49:63-66.
20. Dally N, Hoffman R, Haddad N, Sarig G, Rowe JM, Brenner B: Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia - a single center experience in 34 patients. Thromb Res 2005;116:109-114.
21. Rees D, Grimwade D, Langabeer S, Burnett A, Goldstone A, on behalf of the MRC Adult Leukemia Working Party: Influence of genetic predisposition to thrombosis on natural history of acute promyelocytic leukemia. Br J Haematol 1997;96:490-492.
22. Nowak-Gottl U, Ahlke E, Fleischhack G, Schwabe D, Schobess R, Schumann C, Junker R: Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration. Blood 2003;101:2529-2533.
23. Mitchell LG, Andrew M, Hanna K, Abshire T, Halton J, Anderson R, Cherrick I, Desai S, Mahoney D, Mc Custer P, Wu J, Dahl G, Chait P, Veber G, Lee KJ, Mikulis D, Ginsberg J, Way C; PAARKA Group: A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia treated with Asparaginase (PARKAA) Study. Cancer 2003;97:508-516.